Antimicrobial evaluation of nadifloxacin (OPC-7251), a new topical quinolone, in acne vulgaris.
Vogt
K
K
Department of Microbiology, Rudolf Virchow University Hospital, Berlin, Germany.
Hahn
H
H
Hermann
J
J
Haustein
U F
UF
Blume
U
U
Gollnick
H
H
Orfanos
C E
CE
D000152:Acne Vulgaris / Q000382:microbiology*; D000890:Anti-Infective Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D024841:Fluoroquinolones; D006801:Humans; D008826:Microbial Sensitivity Tests; D011424:Propionibacterium / Q000187:drug effects; D011425:Propionibacterium acnes / Q000187:drug effects; D011807:Quinolizines / Q000494:pharmacology*; D013211:Staphylococcus aureus / Q000187:drug effects
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D011807:Quinolizines; C062127:nadifloxacin